{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T17:40:29Z","timestamp":1740332429009,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1981,4,1]],"date-time":"1981-04-01T00:00:00Z","timestamp":354931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[1981,4]]},"DOI":"10.1007\/bf03189475","type":"journal-article","created":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T17:19:15Z","timestamp":1280683155000},"page":"99-108","source":"Crossref","is-referenced-by-count":4,"title":["Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite"],"prefix":"10.1007","volume":"6","author":[{"given":"F","family":"Sarhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Engasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Batt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Magdalou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Siest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03189475_CR1","first-page":"16","volume-title":"Drug therapy for epilepsy","author":"S. Livingston","year":"1976","unstructured":"Livingston, S. (1976) Drug therapy for epilepsy p. 16, Charles C. Thomas, Springfield, Ill."},{"key":"BF03189475_CR2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1528-1157.1975.tb06065.x","volume":"16","author":"H. Kutt","year":"1975","unstructured":"Kutt H. (1975) Interactions of antiepileptic drugs. Epilepsia, 16, 393\u2013402.","journal-title":"Epilepsia"},{"key":"BF03189475_CR3","first-page":"52","volume-title":"Drug Interaction","author":"P.L. Morselli","year":"1973","unstructured":"Morselli P.L. (1973) Anticonvulsant drug interactions In: Drug Interaction, (Morselli P.L., Cohen S.N. and Garattini S., Eds) pp. 52\u201365, Raven Press, New York."},{"key":"BF03189475_CR4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-3565(25)11753-9","volume":"11","author":"T.C. Butler","year":"1956","unstructured":"Butler T.C. (1956) The metabolic hydroxylation of phenobarbital. J. Pharmacol. Exp. Ther., 11, 326\u2013336.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03189475_CR5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0090-9556(25)05638-7","volume":"1","author":"A.J. Glazko","year":"1973","unstructured":"Glazko A.J. (1973) Diphenylhydantoin metabolism, a prospective review. Drug Met. Disp., 1. 711\u2013714.","journal-title":"Drug Met. Disp."},{"key":"BF03189475_CR6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0022-3565(25)30659-2","volume":"199","author":"T.C Butler","year":"1976","unstructured":"Butler T.C, Dudley K.H., Johnson D. and Robert S.B. (1976) Studies of the metabolism of 5,5-diphenylhydantoin relating principally to the stereoselectivity of the hydroxylation in man and dog. J. Pharmacol. Exp. Ther., 199. 82\u201391.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03189475_CR7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0031-6997(25)07146-7","volume":"19","author":"A.H. Conney","year":"1967","unstructured":"Conney A.H. (1967) Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev., 19, 317\u2013385.","journal-title":"Pharmacol. Rev."},{"key":"BF03189475_CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.0954-6820.1973.tb19444.x","volume":"194","author":"P.B. Andreasen","year":"1973","unstructured":"Andreasen P.B., Lyngbye L. and Trolle E. (1973) Abnormalities in liver function tests during long-term diphenylhydantoin therapy in epileptic patients. Acta Med. Scand., 194. 261\u2013264.","journal-title":"Acta Med. Scand."},{"key":"BF03189475_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(70)90260-8","volume":"1","author":"T.E. Eling","year":"1970","unstructured":"Eling T.E., Harbison R.D., Becker B.A. and Fouts J.R. (1970) Kinetic changes in microsomal drug metabolism with age and diphenylhydantoin treatment. Europ. J. Pharmacol., 1, 101\u2013108.","journal-title":"Europ. J. Pharmacol."},{"key":"BF03189475_CR10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00560345","volume":"7","author":"F. Petruch","year":"1974","unstructured":"Petruch F., Schuppel R.V.A. and Steinhilber G. (1974) Effect of diphenylhydantoin on hepatic drug hydroxylation. Europ. J. Clin. Pharmacol., 7, 281\u2013285.","journal-title":"Europ. J. Clin. Pharmacol."},{"key":"BF03189475_CR11","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1172\/JCI105056","volume":"43","author":"E.E. Werk","year":"1964","unstructured":"Werk E.E., MacGee J.R.J, and Sholiton L.J. (1964) Effect of diphenylhydantoin on Cortisol metabolism in man. J. Clin. Invest., 43, 1824\u20131835.","journal-title":"J. Clin. Invest."},{"key":"BF03189475_CR12","first-page":"676","volume":"28","author":"R.D. Harbison","year":"1969","unstructured":"Harbison R.D., Eling T.E. and Becker B.A. (1969) Effects of diphenylhydantoin on neonatal rat drugmetabolizing enzymes. Fed. Proa, 28, 676.","journal-title":"Fed. Proa"},{"key":"BF03189475_CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.0954-6820.1969.tb07346.x","volume":"185","author":"M. Kristensen","year":"1969","unstructured":"Kristensen M., Hansen J.H. and Skovsted L. (1969) The influence of phenobarbital on the half-life of diphenylhydantoin in man. Acta Med. Scand., 185, 347\u2013350","journal-title":"Acta Med. Scand."},{"key":"BF03189475_CR14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.1971.tb46892.x","volume":"179","author":"P.L. Morselli","year":"1971","unstructured":"Morselli P.L., Rizzo M. and Garattini S. (1971) Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients. Ann. N.Y. Acad. Sci., 179. 88\u2013107.","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BF03189475_CR15","first-page":"449","volume":"21","author":"M. Rizzo","year":"1972","unstructured":"Rizzo M., Morselli P.L. and Garattini S. (1972). Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat Biochem. Pharmacol., 21, 449\u2013454.","journal-title":"Pharmacol."},{"key":"BF03189475_CR16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1528-1157.1976.tb04460.x","volume":"17","author":"J.S. Lockard","year":"1976","unstructured":"Lockard J.S., Levy R.H., Uhlir V. and Farquhar J.A. (1976) Interaction of phenytoin and phenobarbital in terms of order and temporal spacing of administration in monkeys. Epilepsia, 17, 481\u2013485.","journal-title":"Epilepsia"},{"key":"BF03189475_CR17","first-page":"37","volume":"193","author":"J.W. Kemp","year":"1971","unstructured":"Kemp J.W., Tannhauser M. and Swinyard E.A. (1971) Effect of diphenylhydantoin on hexobarbital sleep time in mice and rats. Arch. Int. Pharmacodyn., 193. 37\u201347.","journal-title":"Arch. Int. Pharmacodyn."},{"key":"BF03189475_CR18","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/jps.2600641203","volume":"64","author":"D.M. Soda","year":"1975","unstructured":"Soda D.M. and Levy G. (1975) Inhibition of drug metabolism by hydroxylated metabolites. J. Pharm. Sci., 64, 1928\u20131931","journal-title":"J. Pharm. Sci."},{"key":"BF03189475_CR19","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/jps.2600601110","volume":"60","author":"G.J. Conard","year":"1971","unstructured":"Conard G.J., Haouik C.O. and Finger K.F. (1971) Binding of 5,5-diphenylhydantoin and its major metabolite to human and rat plasma proteins. J. Pharm. Sci., 60. 1642\u20131646","journal-title":"J. Pharm. Sci."},{"key":"BF03189475_CR20","first-page":"297","volume":"4","author":"J.J. Ashley","year":"1972","unstructured":"Ashley J.J. and Levy G. (1972) Inhibition of diphenylhydantoin elimination by its major metabolite. Res. Commun. Chem. Pathol. Pharmacol., 4, 297","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"BF03189475_CR21","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/0024-3205(74)90164-7","volume":"14","author":"S.A. Stavchansky","year":"1974","unstructured":"Stavchansky S.A., Lubawy W.C. and Lostenbauder H.B. (1974) Increase of hexobarbital sleeping and inhibition of drug metabolism by the major metabolite of diphenylhydantoin. Life Sci., 14, 1535\u20131539","journal-title":"Life Sci."},{"key":"BF03189475_CR22","first-page":"75","volume":"8","author":"W.C Lubawy","year":"1974","unstructured":"Lubawy W.C, Kostenbauder H.B. and Stavehansky S.A. (1974) Gross inhibition of drug metabolism by drug metabolites. Increase of zoxazolamine paralysis time by the major metabolite of diphenylhydantoin. Res. Commun. Chem. Path. Pharmacol., 8, 75\u201382","journal-title":"Res. Commun. Chem. Path. Pharmacol."},{"key":"BF03189475_CR23","first-page":"13","volume":"28","author":"C. Bahr Von","year":"1970","unstructured":"Von Bahr C. (1970) Binding to cytochrome P-450 metabolism of desmethylimipramine and metabolites in rat liver imcrosomes. Acta Pharmacol. Toxicol., 28, 13","journal-title":"Acta Pharmacol. Toxicol."},{"key":"BF03189475_CR24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0076-6879(55)01007-0","volume":"1","author":"G.H. Hogeboom","year":"1955","unstructured":"Hogeboom G.H. (1955) Fractionation of cell components of animal tissues. In: Methods in Enzymol., 1, 16, Kaplan, Ed.","journal-title":"Methods in Enzymol."},{"key":"BF03189475_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"O.H. Lowry","year":"1951","unstructured":"Lowry O.H., Rosebrough N.J., Faar A.L. and Randall R.J. (1951) Protein measurement with the Folin reagent J. Biol. Chem., 193, 265\u2013275","journal-title":"J. Biol. Chem."},{"key":"BF03189475_CR26","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/S0021-9258(20)82245-5","volume":"239","author":"T. Omura","year":"1962","unstructured":"Omura T. and Sato N. (1962) The carbon monoxide binding pigment of liver microsomes. II. Solubilization, purification and properties. J. Biol. Chem., 239, 2379\u20132385","journal-title":"J. Biol. Chem."},{"key":"BF03189475_CR27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0021-9258(18)93967-0","volume":"237","author":"C.H. Williams","year":"1962","unstructured":"Williams C.H. and Kamin H. (1962) Microsomal triphosphopyridine nucleotide-cytochrome C reductase of liver. J. Biol. Chem. 237, 587\u2013595","journal-title":"J. Biol. Chem."},{"key":"BF03189475_CR28","first-page":"2129","volume":"23","author":"C.S. Yang","year":"1974","unstructured":"Yang C.S. and Strickhart F.S. (1974) Inhibition of hepatic mixed-function oxidase by propyl gallate. Biochem. Pharmacol., 23, 2129\u20132138","journal-title":"Biochem. Pharmacol."},{"key":"BF03189475_CR29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3565(25)26886-0","volume":"146","author":"K.J. Netter","year":"1964","unstructured":"Netter K.J. and Seidel G. (1964) Kinetic studies of oxidative demethylation of p-nitroanisol by rat liver microsomes. J. Pharmacol. Exp. Ther., 146, 61\u201365","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03189475_CR30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/bj1510131","volume":"151","author":"G.J. Mulder","year":"1975","unstructured":"Mulder G.J. and Van Doom A.B.D. (1975) A rapid NAD-linked assay for microsomal uridine diphosphate glucuronyl-transferase of rat liver and some observations on substrate specificity of the enzyme. Biochem. J., 151, 131","journal-title":"Biochem. J."},{"key":"BF03189475_CR31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0378-4347(00)81595-9","volume":"183","author":"F. Sarhan","year":"1980","unstructured":"Sarhan F., Ziegler J.M., Nicolas A. and Siest G. (1980) Rapid method for simultaneous determination of phenobarbital and diphenylhydantoin and their main hydroxylated metabolites by nitrogen selective GLC J. Chromatogr. 183, 505","journal-title":"J. Chromatogr."},{"key":"BF03189475_CR32","first-page":"409","volume":"23","author":"El Khodjet","year":"1975","unstructured":"Khodjet El Khil R., Batt A.M., Siest G., Thirion P. and Weber M. (1975) Methode de dosage de la diph\u00e9nylhydantoine et du ph\u00e9nobarbital par Chromatographie en phase gazeuse. Path. Biol., 23, 409\u2013416","journal-title":"Path. Biol."},{"key":"BF03189475_CR33","first-page":"128","volume-title":"Drug Measurement and Drug Effect in Laboratory Health Science","author":"F. Sarhan","year":"1980","unstructured":"Sarhan F., Engasser J.M., Letourneur P. and Falcoz C. (1980) Pharmacokinetic models for phenobarbital in the rat In: Drug Measurement and Drug Effect in Laboratory Health Science G. Siest and D. Young Eds. Karger Basel, pp. 128\u2013134"},{"key":"BF03189475_CR34","first-page":"16","volume-title":"Biopharmaceutics and pharmacokinetics","author":"R. Nottari","year":"1975","unstructured":"Nottari R. (1975) Biopharmaceutics and pharmacokinetics; An Introduction Marcel Dekker, New York, pp. 16\u201330"},{"key":"BF03189475_CR35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1042\/bst0060246","volume":"6","author":"J.E. Croft","year":"1978","unstructured":"Croft J.E., Caldwell J. and Smith R.L. (1978) Phenobarbitone disposition in relation to tolerance. Biochem. Soc, Transact, 6, 146\u2013248","journal-title":"Biochem. Soc, Transact"},{"key":"BF03189475_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1476-5381.1971.tb07165.x","volume":"43","author":"C.D. Klaassen","year":"1971","unstructured":"Klaassen C.D. (1971) Biliary excretion of barbiturates. Brit. J. Pharmacol., 43, 161\u2013166","journal-title":"Brit. J. Pharmacol."},{"key":"BF03189475_CR37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0022-3565(25)28838-3","volume":"176","author":"C.D. Klaassen","year":"1971","unstructured":"Klaassen C.D. (1971) Studies on the increased biliary flow produced by phenobarbital in rats. Pharmacol. Exp. Ther., 176, 743\u2013751","journal-title":"Pharmacol. Exp. Ther."},{"key":"BF03189475_CR38","first-page":"98","volume":"270","author":"G. Paugartner","year":"1971","unstructured":"Paugartner G., Harak W. and Probst P. (1971) Effect of phenobarbital on bile flow and bile salt excretion in the rat. Naunyn-Schmiedeberg\u2019s Archiv. Pharmakol., 270, 98\u2013101","journal-title":"Pharmakol."},{"key":"BF03189475_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000197653","volume":"12","author":"J.P. Capron","year":"1975","unstructured":"Capron J.P. and Erlinger S. (1975) Barbiturates and biliary function. Digestion, 12, 43\u201356","journal-title":"Digestion"},{"key":"BF03189475_CR40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0090-9556(25)06315-9","volume":"6","author":"A.M. Hawary El","year":"1978","unstructured":"El Hawary A.M. and Plaa G.L. (1978) Role of the enterohepatic circulation in the elimination of Phenytoin in the rat. Drug. Met. Dispos., 6, 59\u201369","journal-title":"Drug. Met. Dispos."},{"key":"BF03189475_CR41","first-page":"127","volume-title":"Antiepileptic Drugs","author":"A.J. Glazko","year":"1972","unstructured":"Glazko A.J. and Chang T. (1972) Absorption, distribution and excretion of diphenylhydantoin. In: Antiepileptic Drugs, (Woodbury D.M., Penry J.K. and Schmidt R.P., Eds) Raven Press, New York, pp. 127\u2013136"},{"key":"BF03189475_CR42","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0006-2952(78)90444-6","volume":"27","author":"T. Inaba","year":"1978","unstructured":"Inaba T., Umeda T., Endreyi L., Mahon W.A. and Kalow W. (1978) Uptake and metabolism of diphenylhydantoin in the isolated perfused rat liver. Biochem. Pharmacol., 27, 1151\u20131158","journal-title":"Biochem. Pharmacol."},{"key":"BF03189475_CR43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jps.2600620139","volume":"62","author":"G. Levy","year":"1973","unstructured":"Levy G. and Ashley J.J. (1973) Effect of an inhibitor of glucuronide formation on elimination kinetics of diphenylhydantoin in rats. J. Pharm. Sci., 62, 161\u2013162","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03189475\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T17:04:59Z","timestamp":1740330299000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03189475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,4]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1981,4]]}},"alternative-id":["BF03189475"],"URL":"https:\/\/doi.org\/10.1007\/bf03189475","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[1981,4]]}}}